Review article · 2021 · Open access

PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up

Maria Camilla Operti, Alexander Bernhardt, Silko Grimm, Andrea Engel, Carl Gustav Figdor, Oya Tagit

International Journal of Pharmaceutics, 605, 120807 · Published 16 June 2021 · DOI 10.1016/j.ijpharm.2021.120807

Open PDFView at the publisherCite this paper

In brief

“PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up” is a 2021 review article by Maria Camilla Operti and 5 co-authors, published in International Journal of Pharmaceutics. OpenAlex counts 338 citations as of 20 November 2026, which puts it in the top 2% of works published in 2021 by citations. It is open access under a CC BY licence: the full text is free to read at International Journal of Pharmaceutics.

Citations
338
Most cited in
2025 (85)
Field-weighted impact
2.81
References
135
Authors
6

Abstract

Nanomedicines based on poly(lactic-co-glycolic acid) (PLGA) carriers offer tremendous opportunities for biomedical research. Although several PLGA-based systems have already been approved by both the Food and Drug Administration (FDA) and the European Medicine Agency (EMA), and are widely used in the clinics for the treatment or diagnosis of diseases, no PLGA nanomedicine formulation is currently available on the global market. One of the most impeding barriers is the development of a manufacturing technique that allows for the transfer of nanomedicine production from the laboratory to an industrial scale with proper characterization and quality control methods. This review provides a comprehensive overview of the technologies currently available for the manufacturing and analysis of polymeric nanomedicines based on PLGA nanoparticles, the scale-up challenges that hinder their industrial applicability, and the issues associated with their successful translation into clinical practice.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Operti, M. C., Bernhardt, A., Grimm, S., Engel, A., Figdor, C. G., & Tagit, O. (2021). PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up. International Journal of Pharmaceutics, 605, 120807. https://doi.org/10.1016/j.ijpharm.2021.120807

MLA 9

Operti, Maria Camilla, et al. “PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up.” International Journal of Pharmaceutics, vol. 605, 2021, p. 120807. https://doi.org/10.1016/j.ijpharm.2021.120807.

Chicago

Operti, Maria Camilla, Alexander Bernhardt, Silko Grimm, Andrea Engel, Carl Gustav Figdor, and Oya Tagit. 2021. “PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up.” International Journal of Pharmaceutics 605: 120807. https://doi.org/10.1016/j.ijpharm.2021.120807.

Harvard

Operti, M. C. et al. (2021) ‘PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up’, International Journal of Pharmaceutics, 605, p. 120807. doi:10.1016/j.ijpharm.2021.120807.

IEEE

M. C. Operti, A. Bernhardt, S. Grimm, A. Engel, C. G. Figdor, and O. Tagit, “PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up,” International Journal of Pharmaceutics, vol. 605, p. 120807, 2021, doi: 10.1016/j.ijpharm.2021.120807.

BibTeX

@article{operti2021plga,
  title     = {{PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up}},
  author    = {Operti, Maria Camilla and Bernhardt, Alexander and Grimm, Silko and Engel, Andrea and Figdor, Carl Gustav and Tagit, Oya},
  journal   = {International Journal of Pharmaceutics},
  year      = {2021},
  volume    = {605},
  pages     = {120807},
  doi       = {10.1016/j.ijpharm.2021.120807},
  url       = {https://doi.org/10.1016/j.ijpharm.2021.120807}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202199
20223939
20236464
20246060
20258585
20268181

Its field-weighted citation impact is 2.81: it has been cited 2.81 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • PLGA nanoparticles
  • nanomedicine manufacturing
  • industrial scale-up
  • polymeric drug carriers
  • quality control
  • clinical translation
  • biodegradable polymers
  • drug delivery systems

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Operti, M. C., Bernhardt, A., Grimm, S., Engel, A., Figdor, C. G., & Tagit, O. (2021). PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up. International Journal of Pharmaceutics, 605, 120807. https://doi.org/10.1016/j.ijpharm.2021.120807

How many times has this paper been cited?

338 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Pharmaceutics: sign in and open the PDF from this page.

Who wrote this paper?

Maria Camilla Operti, Alexander Bernhardt, Silko Grimm, Andrea Engel, Carl Gustav Figdor, Oya Tagit.

What is the DOI of this paper?

10.1016/j.ijpharm.2021.120807, permanently at https://doi.org/10.1016/j.ijpharm.2021.120807. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.